The Field Application of a Scale Inhibitor Squeeze Enhancing Additive
Authors: Collins I.R. , Cowie L.G. , Nicol M. , Stewart N.J. 
Published: December 2007

Abstract
Barium Sulfate scale deposition in the near-well-bore, perforations or production tubing has severely affected well productivity in many North Sea Fields. This is due to the commingling of the sulfate-rich seawater used for reservoir sweep with formation water containing high concentrations of barium ions. Mitigation of this problem is generally achieved by regular 'squeeze' deployment of scale inhibitor chemicals which retard scale precipitate formation and deposition. In the squeeze procedure, scale inhibitor is injected several feet radially into the production well where it is retained by adsorption and/or formation of a sparingly soluble precipitate. The inhibitor slowly leaches into the produced water over a period of time and protects the well from scale deposition. However, in some instances, the scale inhibitor is poorly retained within the reservoir rock matrix and short squeeze lifetimes are experienced. The net result in these cases is frequent well interventions which impact on both well productivity and field profitability. To solve this problem, a scale squeeze enhancer has been developed (jointly by BP Exploration and BP Chemicals) which acts to enhance retention and subsequent release of scale inhibitor in the reservoir. The first field deployment of this technology was in BP's Magnus asset. The trial demonstrated a more than doubling of the squeeze lifetime of an adsorption chemical and has subsequently led to considerable cost savings for the Magnus asset by reducing well intervention frequency and subsequent well downtime.

Introduction
Magnus Field History. The Magnus oilfield lies approximately 160 km north east of the Shetland Islands in the UK Sector of the North Sea. The field is located in blocks 211/7a and 211/12a, and is producing through the most northerly platform on the UKCS.
The Magnus oilfield was discovered by BP in 1974 and first production commenced in August 1983, reaching a peak annual average production rate of 144,301 stb/day in 1994.
Reservoir Description. The Magnus field is divided into three producing intervals, the Turonian Reworked Sandstone, which overlays the Magnus Sandstone Member (MSM), which overlays the Lower Kimmeridge Clay Formation. The producing interval initially contained an estimated volume of 1,650 mmstb of oil in place. The MSM lies at a sub-sea depth of approximately 3000m and is currently the main producing formation, having originally held 77% of the initial oil in place.
The MSM is the most well defined of the Magnus formations, and can be broken down into several discrete sandstone zones or lobes, separated by shale mudstone units, which act as vertical permeability barriers. The typical MSM permeability is in the range 200–500 mD, with an average porosity of 21% and a maximum net pay of 108 m.
Reservoir Management. The Magnus reservoir is currently being drained by 15 producing wells, while 9 further wells, including 3 sub-sea tie-ins, are injecting seawater to support the reservoir pressure. However, off-take from the field to date has exceeded the volume injected, resulting in a significant drop in reservoir pressure from an original value of 6650 psi to a current average of approximately 3000 psi. In addition, a significant pressure gradient exists across the field, with a maximum of 7500 psi observed in certain injectors, compared with 2750 psi measured in several crestal producers. The field is now produced on a voidage replacement basis, however, significant differential pressure exists between lobes as a result of divergent pressure depletion through the MSM.
Nature of Scale Problem. An analysis of the ionic composition of the formation waters produced from the various lobes or zones reveals subtle differences in their chemistry; however, in each case the produced water has a salinity almost identical to sea water. In addition, the barium concentration in Magnus formation water is in the range 160–220 mg/l.
P. 161^